NIH-funded research Career grant

Investigating how genetic factors link a common blood condition to heart disease

Official title: Using genomic modifiers to mechanistically link clonal hematopoiesis of indeterminate potential penetrance to coronary artery disease

Funded at Broad Institute, INC. · NIH-10827517 · Data updated 2026-11-12

This study is looking at how a certain genetic change, called CHIP, might be linked to heart disease in older adults, with the goal of finding better ways to prevent heart problems for those at risk.

More Coronary Artery Disease research and trials

Quick facts

Grant typeCareer grant
Study typeNIH-funded research
Funding institutionBroad Institute, INC.
NIH-funded
Lab location1 site (Cambridge, United States)
Project startJuly 1, 2023
Project endJune 30, 2025
Funding year2024
Award (this year)$166,860
NIH project number5K99HL165024-02
Project IDNIH-10827517 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are older adults, particularly those over 70 years old, who have been diagnosed with clonal hematopoiesis of indeterminate potential.

Less likely to help

Patients without clonal hematopoiesis or those under 70 years old may not benefit from this research.

What this research studies

This research explores the connection between clonal hematopoiesis of indeterminate potential (CHIP) and coronary artery disease (CAD), particularly in older adults. By analyzing human genomic data and using advanced multi-omics techniques, the study aims to uncover the mechanisms that increase the risk of CAD in individuals with CHIP. The research focuses on understanding specific genetic markers and their roles in the development of heart disease, which could lead to improved prevention strategies for at-risk patients.

Why it matters

Potential benefit: If successful, this research could lead to better prevention and management strategies for heart disease in patients with CHIP.

How similar studies have gone: Previous research has shown promising results in linking genetic factors to cardiovascular disease, indicating that this approach has potential for success.

Where this research is happening

  • Broad Institute, INC.
    Cambridge, United States
    Active

Researchers

  • Principal investigator: Nakao, Tetsushi — Broad Institute, INC.
  • Study coordinator: Nakao, Tetsushi

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.